Results 81 to 90 of about 23,251 (236)

Dupilumab's Real‐World Efficacy and Safety Across Age Groups for Children and Adolescents With Paediatric Atopic Dermatitis

open access: yesAustralasian Journal of Dermatology, EarlyView.
ABSTRACT Background/Objectives Dupilumab is an anti‐interleukin (IL)‐4 receptor (IL‐4Rα) monoclonal antibody used to manage atopic dermatitis (AD). There is a paucity of real‐world Australian data for dupilumab in paediatric AD, especially regarding differences in clinical profiles between age groups.
Paul Sun Woo Kim   +7 more
wiley   +1 more source

Assessment of Interleukin-17A and Interleukin-2 Serum Levels in Patients with Alopecia Areata

open access: yesمجلة الكوفة الطبية
Background: Alopecia areata (AA) is a condition that leads to the loss of hair in the part of the body due to the destruction of hair follicles, and causing patchy, non-scarring hair loss.
Sajjad M. Alfadul   +2 more
doaj   +1 more source

Impact of Dermatology Consult on Inpatient and Acute Care Management of Hidradenitis Suppurativa

open access: yes
JEADV Clinical Practice, EarlyView.
Natalie Baker   +9 more
wiley   +1 more source

Update on Non‐Biological and RNA‐Based Therapeutics in Chronic Inflammatory Diseases: Precision Medicine Through Small Molecules: An EAACI Position Paper

open access: yesAllergy, EarlyView.
ABSTRACT In the last decades, critical advancements in research technology and knowledge on disease mechanisms steered therapeutic approaches for chronic inflammatory diseases towards unprecedented target specificity. For allergic and chronic lung diseases, biologic drugs pioneered this goal, acquiring on the way—through the clinical use of monoclonal ...
F. Roth‐Walter   +20 more
wiley   +1 more source

The causal relationship between gut microbiota and alopecia areata: a Mendelian randomization analysis

open access: yesFrontiers in Microbiology
BackgroundIncreasing evidence suggests a robust correlation between the gut microbiome and alopecia areata. In light of the extensive diversity of gut microbiota, this study aims to utilize state-of-the-art and comprehensive data to explore the causative
Dezhao Bi   +12 more
doaj   +1 more source

A case of new-onset vitiligo in a patient on tofacitinib and brief review of paradoxical presentations with other novel targeted therapies [PDF]

open access: yes, 2020
With recent advancements in the understanding of vitiligo pathogenesis, Janus kinase (JAK) inhibitors have emerged as a promising new treatment modality, but their effects remain incompletely elucidated.
Alikhan, Mujahed   +4 more
core  

Non‐Invasive Scalp Tape‐Strip RNA Sequencing Captures Disease Activity and Treatment‐Response Signatures in Alopecia Areata

open access: yesAllergy, EarlyView.
Non‐invasive scalp tape‐strip RNA sequencing captures core immune and follicular molecular signatures in alopecia areata. Tape‐strip transcriptomic profiles reflect disease severity and treatment response to baricitinib, with concordance to scalp biopsy‐derived signatures.
Carmen Mochón‐Jiménez   +10 more
wiley   +1 more source

Patterns of insurance coverage for wigs in patients with alopecia areata: a cross-sectional survey

open access: yesInternational Journal of Women's Dermatology, 2023
Ogechi Ezemma, BA   +6 more
doaj   +1 more source

Fármacos y productos naturales útiles en el tratamiento de la alopecia y el cabello dañado [PDF]

open access: yes, 2018
Este trabajo consiste en una revisión actual sobre la alopecia y sus posibles tratamientos. La alopecia es un problema hoy en día entre la población, que se define como la disminución o pérdida del cabello, tanto de una manera específica como ...
Quintero Mora, Javier
core  

Covalent drug discovery: Progress against key targets, emerging strategies and lessons learnt

open access: yesBritish Journal of Pharmacology, EarlyView.
Abstract Covalent drug discovery is currently experiencing a boom in industrial and academic interest. To date, at least 75 covalent drugs have received regulatory approval, targeting both traditional target classes and more challenging proteins for which other approaches failed. In many cases, unique aspects of covalent targeting are essential for the
Charles P. Brown   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy